J&J drug Erleada reduces risk of prostate cancer spread, death
Erleada reduced the risk of the cancer spreading or death by 20 per cent. Grouped from 2 articles across 2 sources.
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Erleada reduced the risk of the cancer spreading or death by 20 per cent. Grouped from 2 articles across 2 sources.
Patients on ivonescimab lived longer by four months compared with those on immunotherapy.
China’s manufacturing activity expanded faster than expected in May, according to a private survey released Monday, although growth slowed from April.
Brazil is seeing increasing demand for its vast reserves of rare earth elements. Global mining giants are betting on Brazil as the next powerhouse for critical magnetic metals and an alternative to China's dominance.
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial…
The deaths of two children who had been left in cars during hot weather were the result of their parents' memory failure, a NSW coroner finds.